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Relation to Mitral Valve Annulus and Left Circumﬂex Coronary Artery
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Laurens F. Tops, MD,§ Bernhard Schnackenburg, PHD, Rodolfo Bonamini, MD,†
Jeroen J. Bax, MD,§ Eckart Fleck, MD,‡ Eike Nagel, MD, PHD*
London, United Kingdom; Torino, Italy; Berlin and Hamburg, Germany;
and Leiden, the Netherlands
O B J E C T I V E S To evaluate in vivo anatomical relationships between the coronary sinus–great cardiac
vein (CS–GCV), the mitral valve annulus (MVA), and left circumﬂex coronary artery (LCX) with cardiovascular
magnetic resonance.
B A C KG ROUND The CS–GCV has become an anatomical structure of interest because it provides a
way of access to the heart for a number of interventional procedures. Previous reports demonstrate that the
postulated close anatomical proximity of the CS–GCV to the MVA does not always hold true in patients, both
in autopsy specimens and in vivo by computed tomography.
METHOD S In 31 participants (24 volunteers and 7 patients; 15 men; 42  19 years), cardiovascular
magnetic resonance was performed for noninvasive evaluation of the coronary sinus and of the coronary
arteries using whole-heart imaging and intravascular contrast agents. Three-dimensional reconstructions,
standard orthogonal planes, and unprocessed raw data were used to assess CS–GCV anatomy and its relation
to the MVA and the LCX along their entire course.
R E S U L T S The CS–GCV was located behind the left atrium in all examined participants, at a minimum
distance of 8.6  3.9 mm from the MVA. In 80% of the participants, the LCX crossed the CS–GCV inferiorly,
between the CS–GCV and the MVA. The CS–GCV and the LCX had a parallel course for 26.2 23.0 mm, with
great variability of location and length. In several participants, the CS–GCV had a long parallel course, but in
other participants, the LCX crossed below the CS–GCV at a discrete point.
CONC L U S I O N S In all participants, the CS–GCV coursed behind the left atrium rather than behind the
MVA. In the majority of the participants, the LCX coursed between the CS–GCV and the MVA. These
anatomical relationships should be kept in mind when referring a patient for interventional procedures
requiring the access to the CS–GCV, and cardiovascular magnetic resonance might provide important
information for the selection of candidates for these procedures. (J Am Coll Cardiol Img 2008;1:
729–38) © 2008 by the American College of Cardiology Foundation
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730he coronary sinus and the great cardiac vein
(CS–GCV) have become anatomical struc-
tures of interest because they are used as an
easy way of access to the heart for several
ifferent procedures, so as to reach the left ventricle
ith pacemaker leads or to administer retrograde
ardioplegia or in a series of different electrophysi-
logical interventional procedures (1,2). Recently, it
as been proposed to use the CS–GCV to perform
ercutaneous mitral valve annulus annuloplasty
PMVA) in patients with functional mitral regur-
itation (3,4). The close relationship between the
S–GCV, the left circumflex artery (LCX), which
sually courses close to the CS–GCV, and the
itral valve annulus (MVA) is the anatomical
ubstrate responsible for the efficacy of the proce-
ure and could predict the complications already
escribed during percutaneous procedures requiring
ccess to the CS–GCV (5–7). Thus, the description
f the anatomic relations between the CS–GCV,
he MVA, and the LCX could be of great value in
the selection of patients considered for
these procedures.
Cardiac magnetic resonance (CMR)
has become an important and sophisti-
cated tool for noninvasive evaluation of
the cardiovascular structures. Thus, the
aim of this study was to evaluate the
feasibility of CMR to depict the relation
between the CS–GCV, the MVA, and the
LCX.
M E T H O D S
tudy population. We examined 31 participants (24
olunteers and 7 patients; 15 men; 41  19 years)
ho received an intravascular contrast agent.
adomer-17 (SH L 643A, Schering, Berlin, Ger-
any) was used within a phase II study to evaluate
he coronary arteries (7 patients and 8 volunteers),
nd gadofosveset (MS-325, EPIX Pharmaceuticals,
ambridge, Massachusetts, and Schering), now
pproved in many countries as Vasovist (Bayer
chering Pharmaceutical, Berlin, Germany), was
lso used within a phase I trial to evaluate the
oronary arteries in the remaining 16 volunteers.
The inclusion criterion for the patients was
uspected or known coronary artery disease with an
ndication for invasive angiography, without a his-
ory of coronary artery bypass grafting. The inclu-
ion criterion for the volunteers was a low likelihood
f coronary artery disease (5% according to the
d
liamond and Forrester criteria). All participants gncluded in the aforementioned trials at our center
ere included in the current retrospective analysis.
Participants with contraindications to CMR or
istory of an anaphylactic reaction to any allergen
ere excluded from the study. Patients were also
xcluded if they had atrial fibrillation or frequent
entricular extrasystoles.
The institutional review board approved the
tudy protocol, and written informed consent was
btained from all participants.
ontrast agents. Gadomer-17 is a gadolinium-
ased intravascular contrast agent. It does not show
onsiderable extravasation to the interstitial space
8). Every patient received a 0.15-mmol/kg body
eight dose that was administered intravenously.
Vasovist is a gadolinium-based intravascular
ontrast agent recently approved for magnetic
esonance angiography of the peripheral vascular
ystem (9 –11). Every volunteer received a 0.05-
mol/kg body weight dose that was administered
ntravenously.
agnetic resonance imaging. All participants were
xamined using a whole body magnetic resonance
ystem (Intera CV 1.5-T, Release 9, Philips,
est, the Netherlands) equipped with a power
radient system (33 mT/m, 160 T/m/s slew rate).
5-element cardiac synergy coil was used for
ignal detection. Cardiac synchronization was
erformed using a vector electrocardiogram. For
egistration of diaphragmatic motion during free
reathing a navigator (gating window: 6 mm)
laced at the right dome of the diaphragm was
sed (12). Identification of the heart and diaphragm
as done using a free-breathing multistack single-
hot 2-dimensional balanced steady-state free-
recession scan with transverse, sagittal, and coro-
al images of the thorax. This scan was required for
lacement of the navigator and planning of the
equences (13). A cine steady-state free-precession
equence with 50 heart phases was performed to
etermine the diastolic rest period of the coronary
rteries.
The start of the acquisition as well as acquisition
uration of the coronary angiography sequences
as adapted to the patients’ individual coronary
rtery rest period with a maximal acquisition time
f 90 ms.
An inversion-prepared 3-dimensional steady-
tate free-precession balanced sequence with the
ollowing parameters was used 2 to 10 min after
dministration of the contrast agent: 110 to 130
ransversal slices, repetition time/echo time/flip an-B B R E V I A T I O N S
N D A C R O N YM S
MR cardiac magnetic
esonance
S–GCV coronary sinus an
he great cardiac vein
CX left circumflex artery
VAmitral valve annulus
MVA percutaneous mitrale  6.4 ms/3.2 ms/85°, fat suppression, SENSE
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731sensitivity encoding; reduction factor 2). The mea-
ured voxel size was 1.18  1.18  1.18 mm3 or
ower, reconstructed to 0.7  0.7  0.9 mm3 or
etter (up to 0.7  0.7  0.7 mm3); the field of
iew was 340  340 mm; and the bandwidth was
60 Hz/pixel. Pre-pulse delay was individually de-
ermined with a Look-Locker sequence before the
ontrast-enhanced scan.
mage analysis. Data were analyzed on a post-
rocessing workstation (Viewforum Release
.2V1L2, Philips Medical Systems, Best, the Neth-
rlands). A multiplanar curved reconstruction of the
S–GCV was obtained by the Soapbubble program
MR-Software/Pride, Philips Medical Systems), si-
ultaneously displaying multiple vessels in a
-dimensional representation (14).
NATOMICAL AND QUANTITATIVE ANALYSES.
hree-dimensional volume-rendered reconstruc-
ions and reconstructed standard long-axis 2-, 3-,
nd 4-chamber projections of the left ventricle were
sed to assess the position of the CS–GCV in
elation to the MVA and the LCX with respect to
he CS–GCV and their relative positions at their
rossing point.
Reconstructed long-axis views in the 2-, 3-, and
-chamber projections of the left ventricle were
sed to assess the course of the CS–GCV and to
easure its diameters and the distance between the
S–GCV and the MVA, which is defined as the
istance from the MVA plane to a parallel line
rawn through the center of the CS–GCV (Fig. 1).
he diameter of the MVA was measured in the
Figure 1. Multiplanar-Reformatted Views Representing the Con
The 2-chamber (A) and 4-chamber (B) views show the measuremen
(CS–GCV) and the mitral valve annulus (MVA) plane (green line). Th
CS–GCV. LA  left atrium; LCX  left circumﬂex coronary artery; LM
RV  right ventricle.ame projections. The diameters of the CS–GCV
ere also measured at its ostium, which is defined
s the site where the CS–GCV makes an angle with
he right atrium.
The course of the LCX and the CS–GCV, the
osition of the MVA, the relative distance of the
S–GCV and MVA, the length of the vessels,
he length of parallel course of the CS–GCV and
he LCX, and the perimeter of the MVA were
etermined by manually tracking the center of each
essel and the points of insertion of the mitral valve
eaflets on unprocessed raw data. Distances were
easured by a specifically designed software tool
hat was created using Labview (National Instru-
ents, Austin, Texas).
tatistical analysis. Continuous data are presented as
ean values SD; categorical data are presented as
requencies and percentages. Differences between
easurements were compared using t test for paired
bservations or using 1-way analysis of variance for
epeated measurements. Differences between vol-
nteers and patients were assessed by independent
amples t test. All statistical analyses were per-
ormed using SAS System (version 9.1, SAS Insti-
ute, Cary, North Carolina). All statistical tests
ere 2-sided, whereas a p value 0.05 was consid-
red significant.
E S U L T S
n all participants, the CS–GCV was visible from
ts origin to the anterior interventricular vein. The
t Separation Between the MVA Plane and the CS–GCV
f the distance between the coronary sinus–great cardiac vein
d line represents a parallel line drawn through the center of the
left main coronary artery; LV  left ventricle; RA  right atrium;stan
ts o
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732ean assessable length was 113.5  14.8 mm
Table 1). The LCX was visible in 29 participants
93.5%), for a mean length of 60  24 mm (Table
). In all participants, it was possible to adequately
rack the insertion points of the mitral valve leaflets
n the ventricular wall and on the subaortic septum.
S–GCV diameters and MVA measurements. The di-
meter of the CS–GCV at the ostium and in the 2-,
-, and 4-chamber views (Table 1) showed a
ignificant decrease in mean size with increasing
istance to the origin of the CS–GCV (p  0.001
n both anteroposterior and superoinferior direc-
ions), and the diameter of the CS–GCV at the
stium and in the 4-chamber view was larger in
atients than in volunteers (Table 3).
The diameter of the MVA was 39 5 mm in the
-chamber view, 36  4 mm in the 3-chamber
iew, and 35  4 mm in the 4-chamber view (p 
.001) (Table 1), without a difference between
olunteers and patients (Table 3). The mean pe-
imeter of the MVA was 121  15 mm.
In all participants, the CS–GCV was adjacent to
he left atrial wall rather than to the MVA. The
ean distance of the CS–GCV to the MVA was
1.1  3.7 mm (range: 5 to 20 mm) in the
-chamber view, 11.1  3.9 mm (range: 4 to 22
m) in the 3-chamber view, and 9.7  3.1 mm
range: 4 to 18 mm) in the 4-chamber view, without
ny significant difference between the locations
p  0.11).
Table 1. CS-GCV Diameter and MVA Measurements, Evaluated
on Raw Unprocessed Data
Type of Measure Measurement (mm) p Value
CS-GCV evaluable length* 113.5 14.8 0.96†
CS-GCV ostial diameter,
anteroposterior;
superoinferior
9.9 4.3; 10.4 4.8
CS-GCV diameter,
anteroposterior;
superoinferior
2-chamber view 7.4 1.7; 8.3 2.1 0.04†
3-chamber view 5.3 1.3; 6.3 2.6 0.13†
4-chamber view 5.2 1.5; 5.5 1.9 0.57†
MVA perimeter‡ 121 15
MVA diameter
2-chamber view 39 5§
3-chamber view 36 4§
4-chamber view 35 4§
*Range: 85 to 148. †p  0.001 for the 1-way ANOVA comparison of CS-GCV
diameter at the ostium and in 2-, 3-, and 4-chamber views. ‡Range: 80 to 140.
§p  0.001 for the 1-way ANOVA comparison of MVA diameter in 2-, 3-, and
4-chamber views.
ANOVA  analysis of variance; CS-GCV  coronary sinus–great cardiac vein;L
MVA  mitral valve annulus.When comparing volunteers and patients, the
ean distance between CS–GCV and MVA was
ignificantly different only in the 4-chamber view,
eing 9  3 mm for volunteers and 12  4 mm for
atients, p  0.008 (Table 3). The minimal dis-
ance between the CS–GCV and the MVA along
ts full course was 8.6 3.9 mm (range: 2 to 15 mm
Table 2]; 7.4  3.3 mm for volunteers and 12.4 
.3 mm for patients, p  0.001 [Table 3]).
The 3-dimensional analysis of the MVA position
n space confirmed that this anatomical structure is
ot located in 1 plane but has a saddle-shaped
onfiguration extending to different planes (Fig. 2,
nline Video 1) (15).
elation between the coronary sinus, the LCX, and the
VA. The relation between the CS–GCV, the
CX, and the MVA are summarized in Table 2.
he minimal distance of the LCX to the MVA was
.6  3.1 mm (range: 3 to 13 mm), without a
ifference between volunteers and patients (Table
). In 2 participants, the LCX was not assessable.
he LCX crossed between the CS–GCV and the
VA in 25 participants (80.6%), and in 4 partici-
ants, the LCX passed above the CS–GCV
12.9%). The minimal distance between the LCX
nd the CS–GCV was 2.7  1.0 mm. The distance
rom the CS–GCV ostium to the LCX crossing
as 71.5  29.9 mm (range: 22 to 100 mm),
ithout any difference between volunteers and pa-
ients. The distance between the CS–GCV and the
VA at the CS–GCV-LCX crossing point was
1.0  4.8 mm (range: 2 to 21 mm), being 9.6 
.8 mm for volunteers and 17.4  3.6 mm for
atients (p  0.001) (Table 3).
The length of the overlap between CS–GCV and
Table 2. Relationship of CS-GCV, LCX, and MVA
Type of Measure Measurement (mm) Range
LCX evaluable* length 60 24 19–97
CS-GCV–MVA minimal
distance
8.6 3.9 2–15
LCX-MVA minimal
distance
7.6 3.1 3–13
CS-GCV–LCX minimal
distance
2.7 1.0 1–11
CS-GCV ostium to LCX
cross length
71.5 29.9 22–100
CS-GCV–LCX parallel
course
22.6 23.0 0–95
CS-GCV–MVA distance
at LCX crossing
11.0 4.8 2–21
*We were able to visualize and evaluate the LCX in 29 of 31 (93.5%)
participants.
LCX  left circumﬂex artery; other abbreviations as in Table 1.CX was highly variable, with a mean parallel
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733ourse of 26.2  23.0 mm (range: 0 to 95 mm). In
everal participants, the CS–GCV and the LCX
ad a long parallel course (Figs. 3A and 3B, purple
ine), also parallel to the MVA (Fig. 3B, yellow
ine). The distance between the CS–GCV and the
CX increased again at the anterior wall of the
eart, where the CS–GCV turned toward the apex
s an anterior interventricular vein. Conversely, in
ther participants, the LCX crossed below the
S–GCV at a discrete point (Fig. 3D), without any
arallel course (Fig. 3E, purple line). In contrast, in
hese participants, the distance from the CS–GCV
o the MVA remained constant (Fig. 3E, yellow
ine).
The overlapping segment of CS–GCV and LCX
as 30 mm long in 18 participants (58.1%) or
onger in 11 participants (35.5%). In 1 participant,
t was possible to identify an anterior U-turn of the
S–GCV pathway around the LCX (Fig. 4A).
igure 4B shows an example of a 3-dimensional
econstruction of the posterior surface of the heart,
emonstrating the position of the CS–GCV adja-
ent to the left atrium.
I S C U S S I O N
his study demonstrates the capability of CMR to
valuate noninvasively the anatomical relation be-
ween the CS–GCV, the MVA, and the LCX. All
he CS–GCV, 94% of the LCX, and 100% of basic
Table 3. Comparison of Volunteers and Patients
Type of Measure Chamber View
CS-GCV–MVA distance, mm 2C
3C
4C
CS-GCV–MVA minimal distance, mm
CS-GCV diameter, vertical; horizontal, mm Ostium
2C
3C
4C
MVA diameter, mm 2C
3C
4C
CS ostium to LCX cross length, mm
CS-GCV–MVA distance at LCX crossing, mm
LCX-MVA minimal distance, mm
CS-GCV–LCX length of parallel course, mm
MVA perimeter, mm
Abbreviations as in Tables 1 and 2.alvular anatomy could be assessed.The major findings of the study are that the
S–GCV is located adjacent to the left atrial wall
ather than at the level of the MVA and that in the
ajority of the participants, the LCX courses be-
ween the CS–GCV and the MVA. The relation
etween the CS–GCV and the LCX is highly
ariable in terms of distance, crossing point, and
ength of the parallel course. All these features can
e evaluated noninvasively using CMR and should
e taken into account when selecting patients for
ercutaneous procedures involving the CS–GCV.
Figure 2. Transparent Reconstruction of the Heart Fused With t
and the MVA
The CS–GCV is represented in blue, the MVA in green, and the LCX
and the LCX show a long parallel course. The MVA shows the typic
Abbreviations as in Figure 1. See Online Video 1.
Volunteers
(n  24)
Patients
(n  7) p Value
11 4 13 4 0.2
11 4 12 5 0.5
9 3 12 4 0.008
7.4 3.3 12.4 3.3 0.001
7 6; 7 6 12 4; 12 3 0.02/0.03
8 2; 7 2 8 1; 8 5 0.1/0.4
6 3; 5 1 7 3; 6 2 0.5/0.02
5 2; 5 1 7 2; 7 2 0.01/0.005
39 5 39 3 0.9
36 3 36 5 0.7
35 3.9 37 3 0.2
74 22 74 52 (n  5) 0.4
9.6 3.8 17.4 3.6 (n  5) 0.001
7.1 3.0 9.4 2.5 0.1
29 23 29 18 (n  5) 0.2
113 13 123 14 0.13he CS–GCV, the LCX,
in red. The CS–GCV
al saddle shape.
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734natomical and quantitative observations. The rela-
ions between the CS–GCV, the MVA, and the
CX were previously described in some anatomical
tudies (16–18). Several reports described the pos-
ibility of visualizing the venous system of the heart
sing computed tomography (19–21). The relations
etween the CS–GCV, the MVA, and the LCX were
nvestigated noninvasively (22–24) (Table 4).
A constant separation exists between the CS–
CV and the MVA. In our study, the CS–GCV
as always located adjacent to the left atrial wall
ather than to the MVA, which agrees with the
ndings of previous studies (16–18,23,24) (Table 4).
Furthermore, we observed among patients a
arger separation between the CS–GCV and the
VA in the 4-chamber view when compared with
he separation in volunteers. These data confirm the
Figure 3. Three-Dimensional Representation and Measurements
and the LCX Along Their Entire Course
(A) Three-dimensional reconstruction showing a case with a long p
CS–GCV and the closest point of the LCX (purple line); distance be
(yellow line). (C) Curved multiplanar reformatting showing the L
Three-dimensional reconstruction showing a case with a discrete cr
CS–GCV and the LCX (purple line); the distance of the CS–GCV from
nar reformatting showing the LCX crossing down the CS–GCV in th
descending coronary artery; MV  mitral valve; other abbreviationsesults reported by Choure et al. (23), who found the same increase among patients with mitral re-
urgitation and suggested a possible flattening of
he MVA saddle shape, which may result in a
eduction of the forces for mitral valve leaflet
losure (25). In our population, a larger diameter of
he CS–GCV in this position may also have con-
ributed to this result (Table 3).
The minimal distance of the CS–GCV along its
ourse from the MVA has been previously reported
17,24). We confirmed that even the minimum
istance of the CS–GCV from the MVA is not
egligible, and we demonstrated that the minimal
istance between the CS–GCV and the MVA was
ncreased among patients.
Surprisingly, we found that the relation between
he CS–GCV and the LCX was much closer than
hat between the CS–GCV and the MVA. In fact,
the Anatomical Relationship Between the CS–GCV, the MVA,
el course of the CS–GCV and the LCX. (B) Distance between the
n every point of the CS–GCV and the closest point of the MVA
unning parallel to the CS–GCV in the same participant. (D)
g of the LCX under the CS–GCV. (E) Distance between the
e MVA remains quite constant (yellow line). (F) Curved multipla-
me participant. Ao  ascending aorta; LAD  left anterior
n Figure 1.of
arall
twee
CX r
ossin
th
e sahe minimum distance of the CS–GCV along its
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735ourse from the LCX was 1.3 1 mm in a previous
tudy (24). We detected a small minimal distance
etween the CS–GCV and the LCX (2.7 1 mm),
onfirming the tight relation between the CS–GCV
nd the LCX. Furthermore, the LCX crossed
etween the CS–GCV and the MVA in a large
Figure 4. Three-Dimensional Reconstructions Showing the Anat
Structures in the Atrioventricular Groove, and the Close Relatio
(A) Three-dimensional reconstruction (anterior view) showing the p
the CS–GCV (U). (B) Three-dimensional reconstruction (posterior vie
atrial wall rather than the MVA. The coronary arteries have been re
posterior interventricular vein; other abbreviations as in Figures 1 a
Table 4. Summary of Data Available From Studies About the An
Method
Number
of Patients
CS-GCV
Located
Behind
Left Atrium
CS-GCV–M
Posterio
Distanc
(mm)
Shinbane et
al. (16)
Anat 10 100% 14.1 3.
El-Maasarany
et al. (17)
Anat 40 92.5% 9.4†
Maselli et al.
(18)
Anat 61 100% 9.7 3.
Mao et al.
(22)
CT 231 — —
Choure et al.
(23)
CT 36 100% 10.4 2.
Tops et al.
(24)
CT 105 90% 8.8 2.
Chiribiri et al.
(current
study)
CMR 31 100% 11.1 3.
*At 20 mm from CS ostium. †At 36° rotation from the CS ostium; ‡At P3 scallo
Anat  anatomical dissection of human cadaver hearts; CS  coronary sinusand 2.roportion of patients. We also carefully described
he other characteristics of the relation between
S–GCV and LCX. In particular, the initial cross-
ng point between the CS–GCV and the LCX was
sually located in the lateral region of the heart, at
mean distance from the CS–GCV ostium of 71.5
cal Variability of the Relationships Between the Vascular
ip Between the CS–GCV and the Left Atrial Wall
on of the CS–GCV and of the LCX, which makes a U-turn around
howing the position of the CS–GCV, which is adjacent to the left
ed for better visualization of the atrioventricular groove. PIV 
.
mical Relation Between CS-GCV, MVA, and LCX
Minimum
CS-GCV–MVA
Distance
(mm)
Minimum
CS-GCV–LCX
Distance
(mm)
LCX
Between
CS-GCV
and
MVA
CS-GCV–LCX
Overlap
>30 mm
Dista
CS-Ost
to LC
Cross
(mm
— — — — —
5.2 1.6 — 95.2% — —
— — 69.3% — —
— — 80.8% 17.8% —
— — 80% — 78.2
5.1 2.9 1.3 1.0 68% — —
8.6 3.9 2.7 1.0 80.6% 35.5% 71.5
el of the mitral valve; §2-chamber view; At “proximal CS.”
 computed tomography; CMR  cardiovascular magnetic resonance; other abomi
nsh
ositi
w) s
movato
VA
r
e
nce
ium
X
ing
)
CS-GCV–MVA
Distance at
CS-GCV–LCX
Crossing
(mm)
1* —
—
2‡ —
—
0§ 18.7 8.0 2.0
3 —
7§ 29.9 11.0 4.8
p lev
; CT breviations as in Tables 1
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736m. The CS–GCV also was separated from the
VA at this level, with an increase of its diameter
nd distance among patients.
Moving from this point to the anterior side of the
eart, the relation between the CS–GCV and the
CX showed 2 different patterns: in several pa-
ients, the 2 vessels coursed parallel for a long tract,
ut in others they crossed in a discrete point (Fig.
). Previously, only 1 study (22) partially described
his relation. Mao et al. (22) found a parallel course
etween the CS–GCV and the LCX longer than 30
m in 17.8% of cases. In our study, it was possible
o depict carefully the details of this anatomical
elation. The length of the CS–GCV–LCX parallel
ourse was highly variable, and we demonstrated
hat 35.5% of participants revealed a parallel course
onger than 30 mm, with a high anatomical vari-
bility, suggesting an even tighter relation between
he 2 vessels than has previously been reported.
mplications for PMVA. Even though highly attrac-
ive, PMVA might be applied only to a subset of
atients, due to the mechanism of mitral valve
egurgitation and the anatomical relations demon-
trated by the current study (25) (Table 4). In fact,
hen the CS–GCV courses along the left atrial
all, PMVA may not be useful and might even alter
he size and shape of the MVA in a negative
anner (23), resulting in a mitral annular deforma-
ion through secondary tension effects from the left
trial wall and leading to suboptimal results (25).
urthermore, although the venous system in all
articipants crossed from the atrial side of the
VA to the ventricular side, this always happened
n a discrete point and was different from what
appened with the CS–GCV–LCX crossing point,
hich was represented by a parallel course at least in
subgroup of the participants.
Another potential concern with CS–GCV device
mplantation is the compression of the coronary
rteries, and LCX compression has been reported
uring PMVA in both human and animal studies
26). Not all of these crossovers will necessarily
esult in coronary artery flow reduction (25), but the
ariability of the relation between the CS–GCV
nd the LCX demonstrated by our study may result
n an important technical limitation of PMVA (27).
urther studies will be needed to ascertain whether
he risk of LCX compression is higher when the
CX crosses inferior to the CS–GCV and over a
arge distance (Fig. 3).
In previous studies, the CS–GCV coursed adja-
ent to the MVA in only a small subset (0% to 9%
f patients) (16,18,23,24), and the LCX did not qross under the CS–GCV in a minority of patients,
arying from 4.8% to 30.7% (17,18). The PMVA
evices might also displace rather than compress
he LCX. Furthermore, the distance of the CS–
CV–LCX crossing point from the CS–GCV
stium could be of great importance in selecting
atients for whom PMVA might be useful, as the
itral annular size needs to be decreased by 20% to
0% to achieve a significant reduction in mitral
egurgitation (3). This reduction could not be
ossible in patients with the vessels crossing within
5% of the proximal end of the coronary sinus (3).
The anatomy of the CS–GCV, MVA, and LCX
eeds to be assessed before considering PMVA.
henever possible, this evaluation should be per-
ormed noninvasively to determine whether a trans-
enous approach for the reduction of mitral regur-
itation is feasible. The present study demonstrates
or the first time that CMR is capable of a complete
valuation of the relevant anatomical features of the
egion (25). The main advantage of CMR, besides
ts safety profile, is flexibility with respect to the
natomical needs. Computed tomography requires
he use of X-rays and iodine contrast agents and
ses rectangular data acquisition. Conversely, CMR
oes not require the use of radiation, is considered
safe procedure, and is more flexible and close to
he anatomical situation because of its multidimen-
ional capability. Only a small number of papers
ave been published (28–30) about possible serious
ide effects of gadolinium contrast agents in patients
ith end-stage chronic renal disease.
tudy limitations. In this study, we evaluated partic-
pants without heart failure. Whether these findings
re reproducible in dilated hearts, and in patients
ith a left ventricular ejection fraction lower than
5% who could be the target of PVMA, remains to
e demonstrated. Furthermore, we retrospectively
nalyzed participants who were originally enrolled
n clinical studies to evaluate intravascular contrast
gents for coronary artery imaging. All the sequence
arameters, the timing for image acquisition, and
he dosages of the contrast agent were decided on
he basis of the original study design. The admin-
stration of the intravascular contrast agents, re-
ardless of the type used, made it possible to
isualize the CS–GCV and the LCX in all but 2
articipants. Nezafat et al. (31) examined different
echnical modalities to improve CMR vein imaging
nd discussed the differences between systolic and
iastolic image acquisition and different types of
equence. We retrospectively analyzed datasets ac-
uired to evaluate the coronary arteries, choosing a
d
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737iastolic timing. This approach has several advan-
ages: the diastolic resting period is usually longer
han the systolic resting period, making identifica-
ion easier and image acquisition faster, which
educes cardiac motion-related image blurring.
ezafat et al. (31) showed that the diameter of the
ardiac veins changes during the heart cycle, and the
aximum diameter occurs in the end-systolic
hase. However, the choice of the end-diastolic
uiescent phase did not affect the meaning of our
tudy, because the CS–GCV was completely visu-
lized in all the participants. Furthermore, the
S–GCV was always located in correspondence
ith the atrial wall rather than at the level of the
VA. We expect a systolic increase of the distance
f the CS–GCV from the MVA, depending on the
ncrease in the diameter of the left atrium during
he systole.
Nezafat et al. (31) compared different types of7. Takahashi Y, Jais P, Hocini M, et al.
Acute occlusion of the left circumflex
14. Etienne A, Botnar
winkel AM, Boeshen using magnetization transfer preparation in-
tead of no preparation or T2-preparation of the
ontrast. Further studies are needed to determine
he best approach in a clinical setting.
O N C L U S I O N S
he present study shows the feasibility of CMR to
epict the CS–GCV anatomy and its relation to the
VA and LCX. An accurate selection of potential
andidates for interventions requiring access to the
S–GCV is needed, and CMR can provide the
equired anatomical information.
eprint requests and correspondence: Prof. Dr. Eike Nagel,
ing’s College London, Division of Imaging Sciences, The
ayne Institute, 4th Floor Lambeth Wing, St. Thomas’s
ospital, London SE1 7EH, United Kingdom. E-mail:equences, demonstrating the best image quality eike.nagel@kcl.ac.uk1
1
1
1
1
2E F E R E N C E S
1. Gaita F, Riccardi R, Caponi D, et al.
Linear cryoablation of the left atrium
versus pulmonary vein cryoisolation in
patients with permanent atrial fibril-
lation and valvular heart disease: cor-
relation of electroanatomic mapping
and long-term clinical results. Circu-
lation 2005;111:136–42.
2. Jais P, Hocini M, Hsu LF, et al.
Technique and results of linear abla-
tion at the mitral isthmus. Circulation
2004;110:2996–3002.
3. Duffy SJ, Federman J, Farrington C,
Reuter DG, Richardson M, Kaye
DM. Feasibility and short-term effi-
cacy of percutaneous mitral annular
reduction for the therapy of functional
mitral regurgitation in patients with
heart failure. Catheter Cardiovasc In-
terv 2006;68:205–10.
4. Webb JG, Harnek J, Munt BI, et al.
Percutaneous transvenous mitral an-
nuloplasty: initial human experience
with device implantation in the coro-
nary sinus. Circulation 2006;113:
851–5.
5. Morady F, Strickberger A, Man KC,
et al. Reasons for prolonged or failed
attempts at radiofrequency catheter
ablation of accessory pathways. J Am
Coll Cardiol 1996;27:683–9.
6. Pappone C, Oral H, Santinelli V, et
al. Atrio-esophageal fistula as a com-
plication of percutaneous transcathe-
ter ablation of atrial fibrillation. Cir-
culation 2004;109:2724–6.coronary artery during mitral isthmus
linear ablation. J Cardiovasc Electro-
physiol 2005;16:1104–7.
8. Herborn CU, Barkhausen J, Paetsch I,
et al. Coronary arteries: contrast-
enhanced MR imaging with SH L
643A—experience in 12 volunteers.
Radiology 2003;229:217–23.
9. Parmelee DJ, Walovitch RC, Ouellet
HS, Lauffer RB. Preclinical evaluation
of the pharmacokinetics, biodistribu-
tion, and elimination of MS-325, a
blood pool agent for magnetic reso-
nance imaging. Invest Radiol 1997;32:
741–7.
10. Bluemke DA, Stillman AE, Bis KG,
et al. Carotid MR angiography: phase
II study of safety and efficacy for
MS-325. Radiology 2001;219:
114 –22.
11. Grist TM, Korosec FR, Peters DC, et
al. Steady-state and dynamic MR an-
giography with MS-325: initial expe-
rience in humans. Radiology 1998;
207:539–44.
12. Jahnke C, Paetsch I, Nehrke K, et al.
Rapid and complete coronary arterial
tree visualization with magnetic reso-
nance imaging: feasibility and diag-
nostic performance. Eur Heart J 2005;
26:2313–9.
13. Prakken NH, Vonken EJ, Velthuis
BK, Doevendans PA, Cramer MJ. 3D
MR coronary angiography: optimiza-
tion of the technique and preliminary
results. Int J Cardiovasc Imaging
2006;22:477–87.RM, Van Muis-
iger P, ManningWJ, Stuber M. “Soap-Bubble” visual
ization and quantitative analysis of 3D
coronary magnetic resonance angio-
grams. Magn Reson Med 2002;48:
658–66.
5. Salgo IS, Gorman JH III, Gorman
RC, et al. Effect of annular shape on
leaflet curvature in reducing mitral
leaflet stress. Circulation 2002;106:
711–7.
6. Shinbane JS, Lesh MD, Stevenson
WG, et al. Anatomic and electro-
physiologic relation between the cor-
onary sinus and mitral annulus: impli-
cations for ablation of left-sided
accessory pathways. Am Heart J 1998;
135:93–8.
7. El-Maasarany S, Ferrett CG, Firth A,
Sheppard M, Henein MY. The coro-
nary sinus conduit function: anatomi-
cal study (relationship to adjacent
structures). Europace 2005;7:475–81.
8. Maselli D, Guarracino F, Chiar-
amonti F, Mangia F, Borelli G, Min-
zioni G. Percutaneous mitral annulo-
plasty: an anatomic study of human
coronary sinus and its relation with
mitral valve annulus and coronary ar-
teries. Circulation 2006;114:377–80.
9. Jongbloed MR, Lamb HJ, Bax JJ, et
al. Noninvasive visualization of the
cardiac venous system using multislice
computed tomography. J Am Coll
Cardiol 2005;45:749–53.
0. Gerber TC, Sheedy PF, Bell MR, et
al. Evaluation of the coronary venous
system using electron beam computed
tomography. Int J Cardiovasc Imaging
2001;17:65–75.
22
2
2
3
3
K
c
a
c
m
r
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 , N O . 6 , 2 0 0 8
N O V E M B E R 2 0 0 8 : 7 2 9 – 3 8
Chiribiri et al.
CMR of Coronary Sinus and Mitral Valve Annulus
7381. Van de Veire NR, Schuijf JD, De
Sutter J, et al. Non-invasive visualiza-
tion of the cardiac venous system in
coronary artery disease patients using
64-slice computed tomography. J Am
Coll Cardiol 2006;48:1832–8.
2. Mao S, Shinbane JS, Girsky MJ, et al.
Coronary venous imaging with electron
beam computed tomographic angiogra-
phy: three-dimensional mapping and
relationship with coronary arteries. Am
Heart J 2005;150:315–22.
3. Choure AJ, Garcia MJ, Hesse B, et al.
In vivo analysis of the anatomical re-
lationship of coronary sinus to mitral
annulus and left circumflex coronary
artery using cardiac multidetector
computed tomography: implications
for percutaneous coronary sinus mitral
annuloplasty. J Am Coll Cardiol 2006;
48:1938–45.
4. Tops LF, Van de Veire NR, Schuijf
JD, et al. Noninvasive evaluation of
coronary sinus anatomy and its rela-
tion to the mitral valve annulus: im-
plications for percutaneous mitral an-nuloplasty. Circulation 2007;115:
1426–32.
25. Piazza N, Bonan R. Transcatheter
mitral valve repair for functional mi-
tral regurgitation: coronary sinus ap-
proach. J Interv Cardiol 2007;20:
495–508.
26. Maniu CV, Patel JB, Reuter DG, et
al. Acute and chronic reduction of
functional mitral regurgitation in ex-
perimental heart failure by percutane-
ous mitral annuloplasty. J Am Coll
Cardiol 2004;44:1652–61.
27. Feldman T, Glower D. Patient selec-
tion for percutaneous mitral valve re-
pair: insight from early clinical trial
applications. Nat Clin Pract Cardio-
vasc Med 2008;5:84–90.
28. Grobner T. Gadolinium—a specific
trigger for the development of neph-
rogenic fibrosing dermopathy and
nephrogenic systemic fibrosis?
Nephrol Dial Transplant 2006;21:
1104 – 8.
29. Dharnidharka VR, Wesson SK, Fen-
nell RS. Gadolinium and nephrogenic
F
sfibrosing dermopathy in pediatric pa
tients. Pediatr Nephrol 2007;22:1395.
0. Broome DR, Girguis MS, Baron PW,
Cottrell AC, Kjellin I, Kirk GA.
Gadodiamide-associated nephrogenic
systemic fibrosis: why radiologists
should be concerned. AJR Am J
Roentgenol 2007;188:586–92.
1. Nezafat R, Han Y, Peters DC, et al.
Coronary magnetic resonance vein
imaging: imaging contrast, sequence,
and timing. Magn Reson Med 2007;
58:1196–206.
ey Words: intravascular
ontrast agents y mitral valve
nnulus y coronary sinus y left
ircumflex coronary artery y
itral valve repair y magnetic
esonance imaging
A P P E N D I Xor an accompanying video and legend, please
ee the online version of this article.
